Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PRDM6 antibody (AA 165-452)

This Rabbit Polyclonal antibody specifically detects PRDM6 in WB, ELISA, FACS, ICC and IF. It exhibits reactivity toward Human.
Catalog No. ABIN7871147
$625.62
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for PRDM6 antibody (AA 165-452) (ABIN7871147)

Target

See all PRDM6 Antibodies
PRDM6 (PR Domain Containing 6 (PRDM6))

Reactivity

  • 18
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 18
Rabbit

Clonality

  • 18
Polyclonal

Conjugate

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
This PRDM6 antibody is un-conjugated

Application

Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
  • Binding Specificity

    • 9
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 165-452

    Purpose

    PRDM6 Antibody / PR domain zinc finger protein 6

    Purification

    Immunogen affinity purified

    Immunogen

    E.coli-derived human PRDM6 recombinant protein (Position: R165-R452) was used as the immunogen for the PRDM6 antibody.

    Isotype

    IgG
  • Application Notes

    Optimal dilution of the PRDM6 antibody should be determined by the researcher.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Storage

    4 °C,-20 °C

    Storage Comment

    After reconstitution, the PRDM6 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    PRDM6 (PR Domain Containing 6 (PRDM6))

    Alternative Name

    PRDM6

    Background

    The PRDM6 antibody targets PR domain zinc finger protein 6, a transcriptional repressor encoded by the PRDM6 gene. This protein is a member of the PRDM family, which combines a PR (PRDI-BF1 and RIZ1 homology) domain with multiple C2H2-type zinc fingers to regulate chromatin structure and gene expression. PR domain zinc finger protein 6 acts as an epigenetic modulator that influences vascular smooth muscle cell (VSMC) differentiation, proliferation, and contractility. The PRDM6 antibody allows precise detection of this transcriptional regulator, supporting studies into vascular development, remodeling, and disease.

    PR domain zinc finger protein 6 functions as a transcriptional repressor by recruiting histone methyltransferases and corepressor complexes, leading to trimethylation of histone H3 on lysine 9 (H3K9me3) and gene silencing. It is preferentially expressed in smooth musclei 1/2derived lineages where it regulates genes controlling contractile protein synthesis and cell fate. The PRDM6 antibody provides a reliable means to monitor expression changes during phenotypic switching of VSMCs between contractile and proliferative states, a process central to vascular injury response and atherosclerosis.

    Loss-of-function mutations in PRDM6 have been associated with patent ductus arteriosus (PDA) and other congenital heart defects. These variants impair transcriptional repression of target genes involved in vascular maturation. The PRDM6 antibody facilitates investigation into such pathogenic mechanisms by allowing detection of wild-type and mutant protein forms. In developmental studies, PR domain zinc finger protein 6 has been shown to coordinate the balance between smooth muscle proliferation and differentiation during embryogenesis, acting downstream of BMP and TGF-beta signaling pathways.

    Beyond cardiovascular biology, PR domain zinc finger protein 6 has been implicated in oncogenesis through its role in epigenetic gene silencing. Aberrant PRDM6 expression or methylation patterns have been observed in multiple cancer types, suggesting that dysregulation of this transcriptional repressor contributes to uncontrolled cell growth. The PRDM6 antibody enables detailed exploration of its epigenetic regulatory activity in cancer and stem cell systems, providing insight into how histone modification and chromatin structure impact disease progression.

    The PRDM6 antibody performs effectively in western blotting, immunofluorescence, and immunohistochemistry, showing predominant nuclear localization consistent with its transcriptional role. NSJ Bioreagents provides this antibody with validated specificity and consistency for use in molecular biology, vascular research, and epigenetic studies. By facilitating detailed analysis of PR domain zinc finger protein 6 expression and function, the PRDM6 antibody supports ongoing research into vascular development, gene regulation, and the epigenetic mechanisms that govern smooth muscle cell behavior.

    UniProt

    Q9NQX0

    Pathways

    Regulation of Muscle Cell Differentiation
You are here:
Chat with us!